T-Curx
Bavaria, Germany · Biotechnology, Health Care
T-Curx is a Würzburg, Germany-based biotech company focused on developing next-generation CAR-T cell therapies manufactured using non-viral technologies. The company aims to provide effective cancer therapies for patients suffering from acute myeloid leukemia (AML) and solid tumors. T-Curx utilizes proprietary non-viral CAR-T technologies for scalable and cost-effective manufacturing of CAR-T cell
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Bavaria, Germany
- Employees
- Unknown
- Industries
- Biotechnology, Health Care
- Status
- Private
- Website
- t-curx.com
- Company page
Recent activity at T-Curx
About T-Curx: questions and answers
What does T-Curx do?
T-Curx is a Würzburg, Germany-based biotech company focused on developing next-generation CAR-T cell therapies manufactured using non-viral technologies. The company aims to provide effective cancer therapies for patients suffering from acute myeloid leukemia (AML) and solid tumors. T-Curx utilizes proprietary non-viral CAR-T technologies for scalable and cost-effective manufacturing of CAR-T cell
Where is T-Curx headquartered?
T-Curx is headquartered in Bavaria, Germany.
What is the latest news on T-Curx?
On Sep 30, 2026, T-CURX Appoints Florian Schmid as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy